ClinicalTrials.gg
Sign In

Liver Neoplasms clinical trials

The registry lists 1,345 studies for Liver Neoplasms across more than 10 countries. 335 are recruiting or about to start. 533 of them are mainly about Liver Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 2 narrower conditions too, such as Carcinoma, Hepatocellular: 4,475 studies, 1,299 open.

ClinicalTrials.gov finds 5,490 studies for Liver Neoplasms. How that becomes 1,344 here

This page counts the studies the registry files under Liver Neoplasms, and those it files under no condition that list Liver Neoplasmsthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 5,490Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −2,880Filed under a narrower condition, counted on its own pageCarcinoma, Hepatocellular 2,853 · Fibrolamellar hepatocellular carcinoma 4
  3. −37List Liver Neoplasms as a condition, but the registry did not file them under itMost often written as “Colon Cancer Liver Metastasis” (10), “Recurrent Childhood Liver Cancer” (7), and “Colorectal Cancer Liver Metastasis” (4). The registry filed them under other conditions only, most often Colorectal Neoplasms (14) and Colonic Neoplasms (9).
  4. −1,229Match it another way135 name it in the title, 13 in a keyword, and 1,081 by a synonym or other text the search reads.
  5. 1,344The count on this page52 of them list Liver Neoplasms in their own words; the registry filed them under no condition.

Get an email when these change. Save the Liver Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
559
Recruiting
244
Status unknown
189
Terminated
133
Not yet recruiting
75
Active, not recruiting
70

Phase

Phase 2
366
Phase 1
293
Phase 3
98
Phase 4
40
Early Phase 1
15

Where

United States
566
China
309
France
93
Taiwan
81
Italy
79
Korea, Republic of
78

Who runs them

National Cancer Institute (NCI) (34) · M.D. Anderson Cancer Center (24) · Sun Yat-sen University (23) · Memorial Sloan Kettering Cancer Center (22) · National Taiwan University Hospital (16) · National Institutes of Health Clinical Center (CC) (16) · Bayer (15) · Fuda Cancer Hospital, Guangzhou (14)

What is being tested here

Drugs under test in Liver Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Lenvatinib8214
Durvalumab5313
Pembrolizumab518
Ipilimumab417
Apatinib405
Camrelizumab404
Sintilimab304
Gallium-68313
Bevacizumab2226
Toripalimab206

Drug classes tested here Immune checkpoint inhibitors 23 open · Tyrosine kinase inhibitors (TKIs) 13 open · Antimetabolites 3 open · Angiogenesis inhibitors 2 open · Alkylating agents 1 open

Coming up

15phase 3 studies under way
109studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 244 Liver Neoplasms studies recruiting now, 138 (57%) set no upper age limit and 69 (28%) stop at 75 or younger. 14 (6%) take children under 18. 1 (<1%) are for women only and 0 (0%) for men only; 34 (14%) take healthy volunteers.

Recruiting studies that take each age, of 244
AgeWomenMen
1011 (5%)11 (5%)
18224 (92%)223 (91%)
30237 (97%)236 (97%)
40238 (98%)237 (97%)
50239 (98%)238 (98%)
65238 (98%)237 (97%)
75220 (90%)219 (90%)
85155 (64%)155 (64%)

Across all 1,345 studies, recruiting or not: 20% stop at 75 or younger and 4% at 65; 8% take children; <1% are for women only and <1% for men only; 7% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Liver Neoplasms studies take

Of 99 phase 1 interventional studies under Liver Neoplasms, half reached primary completion within 49 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 149 mo32–65 · 99 studies49 mo28–66 · 51 studies51 mo33–63 · 48 studies
Phase 1/259 mo44–72 · 33 studies——
Phase 257 mo37–100 · 86 studies—65 mo37–103 · 72 studies
Phase 357 mo38–97 · 30 studies——
Interventional, no phase39 mo18–73 · 168 studies—44 mo18–82 · 149 studies
Observational59 mo34–172 · 160 studies—114 mo34–172 · 132 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting2

Results posted3

Newly registered7

Show 2 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,345. Browse all 1,345 → or search them.